Global Since monkeypox was declared a global emergency by the World Health Organization (WHO) and industrialized countries began stockpiling vaccines, Bavarian Nordic’s shares have more than tripled while Siga Technologies has seen the value of its stock double. … we are pleased to assist more countries with supply of vaccines…
Canada Some of the top stories coming out of Canadian healthcare and life sciences, including a new GSK flu vaccine deal, Amylyx Pharmaceuticals’ first approval for an ALS drug, and the Public Health Agency of Canada’s recent smallpox contracts with Chimerix and Bavarian Nordic. GSK flu vaccine deal renewal (Reuters)…
Singapore Kenneth Tan has been President for Asia Pacific & Japan at cancer-focused medical device player Varian since February 2019. In a recent conversation with PharmaBoardroom, Tan shared how an early passion for healthcare has blossomed into an impressive global career in pharmaceuticals and MedTech, why a multidisciplinary, collaborative and patient-centric…
Spain Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no exception with Galician billionaire Amancio Ortega Gaona, the 82-year-old owner of clothing empire Inditex Fashion Group, which comprises iconic brands such as Zara and Massimo Dutti, embarking upon something of a spending spree…
Algeria Mourad Belkheyar, acting director general of Varian Healthcare Algeria lifts the lid on the progress Algeria has made in its quest to bring the most advanced radiotherapies to Algeria. He discusses the critical role of Varian healthcare in training engineers, operating, and maintaining such complex machinery, to improve the prognosis…
Asia-Pacific Kevin O’Reilly, president for the APAC region at medtech giant Varian, discusses his key priorities, the importance of Asia to the global group, new technology adoption, and the importance of inter-stakeholder collaboration. Diversity has been a major factor in our interest in this region, and by becoming closer to…
Austria Mario Huber, general manager of PharmaMar Austria, a multinational and an innovative oncology-based Spanish company, discusses the growth of the company in Austria and the reasons behind the success of Yondelis®, the company’s flagship product. Furthermore, he provides an overview of the clinical trials the Austrian affiliate is undertaking and…
Bavarian Nordic If there is one thing that successful Danish companies have in common with one another, it is the clear recognition of abundant opportunities outside the motherland. “Danish companies’ strengths lie in their ability to build on what they have inherited from Denmark but to also look outward and be…
See our Cookie Privacy Policy Here